Dr. Amy Wilstermann
Biography
Dr. Wilstermann is associate director of the Calvin Honors Program. She is also the advisor for Calvin's Pre-Occupational Health program and Pre-Physician Assistant program.
Dr. Wilstermann enjoys doing research at Calvin because it provides her with the opportunity to work closely with very talented and curious students. Her students often ask wonderful, thought-provoking questions that prompt the exploration of new research avenues.
Outside of Calvin, Amy enjoys spending time with family. They can often be found outdoors - at a local park or at the beach. She also enjoys baking, ice skating, reading, and spending time with extended family and friends.
Education
- BS in Biochemistry, Oakland University, 1995
- PhD in Biochemistry, Vanderbilt University, 2002
Professional Experience
Prior to joining the faculty at Calvin, Dr. Wilstermann taught at a Christian university in Nashville, TN where she also served as the coordinator of the science and mathematics department. She joined the faculty of Calvin in 2007 and currently teaches Cell Biology and Genetics, Cell Physiology, General Biology and Human Biology.
Academic Interests
Research and Professional Interests
- DNA topoisomerases
- Interactions between chemotherapeutic agents and their cellular targets
- DNA-enzyme interactions
- Active-learning pedagogies
Research
- Dr. Amy Wilstermann is developing materials to improve children's understanding of cancer. She and her research student, Sara Conrad, found a lack of teaching materials about cancer targeted to children. They focused on developing a curriculum focusing on four sections: introducing children to the basic scientific concepts of cancer, teaching about the most common cancers for children under age 9, leukemia and lymphoma, presenting information about cancer treatments, and lastly helping children find ways to care for others with cancer.
- Dr. Wilstermann has also investigated the role of bacteria in the Premature Rupture of Fetal Membranes. She focused on studying the shift from a healthy vaginal environment to bacterial vaginosis conditions, which causes negative effects in reproduction, pregnancy. and contracting STD's.
Research and Scholarship
Rare Disease Research & Support
Rare diseases are those that affect less than 200,000 people in the United States. However, since there are over 7,000 different types of rare diseases, on average 1 in 10 people has a rare disease. This means that most people know someone or are someone who has rare disease. Calvin University Rare Disease Research & Support was started in response to the unmet needs of our rare disease community in West Michigan. Our goal is to reach beyond our student community to develop meaningful relationships between the University and local patients, families, providers, advocates, educators, and other authorities to help further rare disease education, awareness, and empathy. What started as research of BCS1L mutations has since expanded to include other projects in STEM, communications, education, and more giving our students and the greater West Michigan area even more ways to connect with and support our rare community.
Find out more about ways you can participate in this research as a student.
There are more Americans who live with a rare disease than ALL of those who have been diagnosed with HIV, heart disease, or stroke. Find out more about research happening at Calvin University and in the state of Michigan.
Research facts
- 95% of rare disease do not have an FDA approved treatment or therapy.
- Rare diseases with FDA approved treatments still have high costs and variability, limiting their accessibility.
- Approximately 50% of the people affected by rare diseases are children, and 30% of those children will not live to see their 5th birthday.
- Rare diseases also offer an opportunity to better understand how our bodies function, which better enables us to understand and combat diseases that are designated as common diseases, including cardiovascular disease (56,888,289 deaths in 2008), infectious and parasitic diseases (8,721,166 deaths in 2008), diabetes (1,255,585 deaths in 2008), and Alzheimer’s and other dementias (539,948 deaths in 2008).1
Rare disease research at Calvin
At Calvin, our research focuses on rare diseases that cause mitochondrial dysfunction. By studying mitochondrial rare diseases, we hope to advance understanding of particular rare diseases as well as increase our understanding of mitochondrial function and its role in common diseases. Our goal is to develop model systems and assays that will allow us to differentiate the effects of various mutations so that we can understand and predict the severity of novel mutations. Read more about our current projects..
Rare disease research updates
We recognize that it can be challenging to keep track of what is known about your rare disease. You have enough to do managing your medical care or that of a family member or loved one. Visit our research update page to see summaries of current literature related to select rare diseases. Read more about our current summaries..
1National Organization for Rare Disorders Fact Sheet, NORD, 2016
